(Press-News.org) The U.S. Department of Health and Human Services today issued a Notice of Proposed Rulemaking (NPRM), which proposes regulations to implement reporting requirements for clinical trials that are subject to Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). The proposed rule clarifies requirements to clinical researchers for registering clinical trials and submitting summary trial results information to ClinicalTrials.gov, a publicly accessible database operated by the National Library of Medicine, part of the National Institutes of Health. A major proposed change from current requirements is the expansion of the scope of clinical trials required to submit summary results to include trials of unapproved, unlicensed, and uncleared products.
"Medical advances would not be possible without participants in clinical trials," said NIH Director Francis S. Collins, M.D., Ph.D. "We owe it to every participant and the public at large to support the maximal use of this knowledge for the greatest benefit to human health. This important commitment from researchers to research participants must always be upheld."
ClinicalTrials.gov currently contains registration information for more than 178,000 clinical trials and summary results for more than 15,000. These numbers include trials that are not subject to FDAAA. Among the primary benefits of registering and reporting results of clinical trials, including both positive and negative findings, is that it helps researchers prevent unnecessary duplication of trials, particularly when trial results indicate that a product under study may be unsafe or ineffective, and it establishes trust with clinical trial participants that the information from their participation is being put to maximum use to further knowledge about their condition.
Developed by NIH in close coordination with the FDA, the proposed rule details procedures for meeting the requirements established by FDAAA to improve public access to clinical trial information. FDAAA and the proposed rule apply to certain interventional studies of drugs, biological products, and devices that are regulated by the FDA, but, generally, not to phase 1 trials of drugs and biological products and small feasibility studies of devices. The proposed rule specifies how data collected and analyzed in a clinical trial would be required to be submitted to ClinicalTrials.gov. It would not affect requirements for the design or conduct of clinical trials or for the data that must be collected during clinical trials.
"This proposed rule would close an important gap, making additional information about clinical studies of investigational drugs, medical devices and biological products available to the public," said FDA Commissioner Margaret A. Hamburg, M.D. "It would help eliminate unnecessary duplicative trials, advance biomedical innovation, and provide the public with a much richer understanding about the clinical trials for these products."
Notable changes from current requirements and practice that are outlined in the proposed rule include:
A streamlined approach for determining which trials are subject to the proposed regulations and who is responsible for submitting required information.
Expansion of the set of trials subject to summary results reporting to include trials of unapproved products.
Additional data elements that must be provided at the time of registration (not later than 21 days after enrolling the first participant) and results submission (generally not later than 12 months after completion).
Clarified procedures for delaying results submission when studying an unapproved, unlicensed, or uncleared product or a new use of a previously approved, licensed, or cleared product and for requesting extensions to the results submission deadline for good cause.
More rapid updating of several data elements to help ensure that users of ClinicalTrials.gov have access to accurate, up-to-date information about important aspects of a clinical trial.
Procedures for timely corrections to any errors discovered by the responsible party or by the Agency as it processes submissions prior to posting.
Read a summary of the proposed changes: http://www.nih.gov/news/health/nov2014/od-19_summary.htm (live at 12 p.m. on 11/19).
INFORMATION:
HHS values the public's participation in clinical trials and the knowledge gained by their participation; considers it an obligation to support the maximal use of this knowledge for the greatest benefit to human health; and strongly supports sharing of clinical trial data in a manner that both protects participant privacy, and allows the broader scientific research community to validate and build upon initial clinical trial findings.
The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at http://www.nih.gov/icd/od/.
About the National Library of Medicine (NLM)
The world's largest biomedical library, NLM maintains and makes available a vast print collection and produces electronic information resources on a wide range of topics that are searched billions of times each year by millions of people around the globe. It also supports and conducts research, development, and training in biomedical informatics and health information technology. Additional information is available at http://www.nlm.nih.gov.
About the National Institutes of Health (NIH)
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
Geologists in Syracuse University's College of Arts and Sciences have recently figured out what has caused the Alaska Range to form the way it has and why the range boasts such an enigmatic topographic signature. The narrow mountain range is home to some of the world's most dramatic topography, including 20,320-foot Mount McKinley, North America's highest mountain.
Professor Paul Fitzgerald and a team of students and fellow scientists have been studying the Alaska Range along the Denali fault. They think they know why the fault is located where it is and what accounts ...
It's hard to believe, but there are similarities between bean sprouts and human cancer.
In bean sprouts, a collection of amino acids known as a protein complex allows them to grow longer in the darkness than in the light. In humans, a similar protein complex called CSN and its subunit CSN6 is now believed to be a cancer-causing gene that impacts activity of another gene (Myc) tied to tumor growth.
Somehow the same mechanisms that result in bigger bean sprouts, also cause cancer metastasis and tumor development.
A study at The University of Texas MD Anderson Cancer ...
Human-wildlife conflict resolution near protected areas critical for tiger survival
Stripe-matching software and individual histories inform decisions on handling conflict-prone big cats
NEW YORK (November 18, 2014)--Researchers with the Wildlife Conservation Society and other partners in India are using high-tech solutions to zero in on individual tigers in conflict and relocate them out of harm's way for the benefit of both tigers and people.
In recent tiger-conflict cases involving both a human fatality and the predation of livestock, both occurring near two of ...
Nearly 30,000 people become living kidney donors worldwide each year, and many are young women. Researchers at the Institute for Clinical Evaluative Sciences (ICES), Lawson Health Research Institute and Western University set out to determine if being a living donor has any effect on future pregnancies.
The study, published in the New England Journal of Medicine, found living kidney donors were more likely to be diagnosed with gestational hypertension (high blood pressure) or preeclampsia than non-donors.
Preeclampsia is a pregnancy complication characterized by high ...
South Asian boys are three times as likely to be overweight compared to their peers, according to a new Women's College Hospital study.
The report, which was recently published in the Journal of Racial and Ethnic Health Disparities, was one of the first to look at ethnic group differences in overweight children living in Canada.
"Our findings are alarming. From a young age, South Asian boys appear to be on a path towards developing serious health conditions," said Ananya Banerjee, PhD, lead researcher of the study.
Previous work has established that, in Canada, type ...
Recently published research by U.S. Forest Service economist Jeff Prestemon supports the contention that the 2008 Lacey Act Amendment reduced the supply of illegally harvested wood from South America and Asia available for export to the United States.
Using monthly import data from 1989 to 2013, Prestemon, Project Leader of the Forest Service Southern Research Station Forest Economics and Policy unit, applied alternative statistical approaches to evaluate the effects of the 2008 amendment. The Journal of Forest Policy and Economics recently published the results online. ...
CHICAGO - Women who take a common type of medication to control their blood pressure are not at increased risk of developing breast cancer due to the drug, according to new study by researchers at the Intermountain Medical Center Heart Institute in Murray, Utah.
Researchers analyzed the records of more than 3,700 women who had no history of breast cancer, and who had long-term use of calcium channel blocker medications to control their blood pressure. Researchers found only a minimal increase in risk in one study and a 50 percent reduced risk in a second, leading them ...
Inspired perhaps by Harry Potter's invisibility cloak, scientists have recently developed several ways--some simple and some involving new technologies--to hide objects from view. The latest effort, developed at the University of Rochester, not only overcomes some of the limitations of previous devices, but it uses inexpensive, readily available materials in a novel configuration.
"There've been many high tech approaches to cloaking and the basic idea behind these is to take light and have it pass around something as if it isn't there, often using high-tech or exotic ...
Attending to and caring about the emotions of employees and colleagues - that's for wimps, not for tough businesspeople and efficient performers, right? Wrong! An extensive international study has now shown: The "ability to recognize emotions" affects income. The corresponding author of the study is Professor Dr. Gerhard Blickle of the Department of Psychology at the University of Bonn. The results are published in the Journal of Organizational Behavior.
"Although managing employees and dealing with people often involves reading their emotions and determining their moods, ...
A catastrophic landslide, one of the largest known on the surface of the Earth, took place within minutes in southwestern Utah more than 21 million years ago, reports a Kent State University geologist in a paper being to be published in the November issue of the journal Geology.
The Markagunt gravity slide, the size of three Ohio counties, is one of the two largest known continental landslides (larger slides exist on the ocean floors). David Hacker, Ph.D., associate professor of geology at the Trumbull campus, and two colleagues discovered and mapped the scope of the ...
